Want to thrive in an AI-first world? Our FREE Survival Skills Series gives you new tools to add to your kit.

AI is already reshaping hiring and talent development. Download the State of Tech Talent 2026 for global insights on what's working.



    Begin your learning Pathway

    AI Fundamentals

    Take individual courses or combine them to build end-to-end AI capability for the modern workplace.



    Begin your learning Pathway

    AI Data Analytics

    Take individual courses or combine them to master the tools and methodologies that power modern AI data analytics.



    Begin your learning Pathway

    AI & Machine Learning

    Take individual courses or combine them to master the tools and methodologies that power production-grade AI applications.



    Begin your learning Pathway

    AI Product Management

    Take individual courses or combine them to master the frameworks and methodologies that power successful AI-driven products.



    Begin your learning Pathway

    AI Software Engineering

    Take individual courses or combine them to master the complete AI software engineering stack.



    Begin your learning Pathway

    AI Experience & Design

    Take individual courses or combine them to master the tools and methodologies that power modern AI product design.

    Get More Info
    Carolyn Ng Photo

    Carolyn Ng

    Investment Director (Healthcare), Vertex Ventures

    Singapore

    Carolyn Ng is the Investment Director of Vertex Healthcare Ventures, the VC arm of Temasek Holdings specializing in early stage life sciences investments. She is based in the Singapore office, where she evaluates venture investment opportunities across biotechnology and medical devices sectors globally. Prior to joining Vertex, Carolyn was a Consultant at Deallus Consulting, a specialized life sciences strategy consulting firm. While at Deallus, she led multiple consulting projects for large pharmaceutical companies supporting due diligence of in-/out-licensing opportunities, analyzing competitive landscapes of emerging classes of therapeutics, and formulating go-to-market strategies for Asian markets. Carolyn was also a molecular oncology research scientist in YLL School of Medicine, the National University of Singapore. She was a recipient of the NUS Graduate School for Integrative Sciences and Engineering PhD scholarship, and holds the patent of a novel small molecule nuclear receptor activator indicated for the treatment of neuroblastoma.

    Carolyn holds a PhD in Cancer Molecular Biology from the NUS Graduate School for Integrative Sciences and Technology, and also holds a BS (Pharmacy) (First Class Honours) degree from the National University of Singapore.

    Coming up near you

    Want to teach at ga?

    Join our global community of instructors and help shape the next generation of industry leaders — while moving your own career forward with proven subject matter expertise, leadership experience, and public speaking skills. Teach online or on campus, full-time
or part-time.

    Learn More